查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654674

全球预防保健技术与服务市场 - 2025 年至 2033 年

Global Preventive Healthcare Technologies and Services Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球预防医疗技术和服务市场规模达到 2,652.9 亿美元，预计到 2033 年将达到 7,815.1 亿美元，2025-2033 年预测期内的复合年增长率为 12.2%。

预防性医疗保健技术和服务是当代医疗保健系统的重要组成部分，强调预防疾病和有效管理健康状况的主动策略。该过程涉及利用诊断工具在疾病出现症状之前识别疾病。诊断影像、基因检测和生物标记检测等技术对于早期发现癌症和心血管疾病等病症至关重要，可显着提高治疗成功率和存活结果。

疫苗透过训练免疫系统识别和对抗病原体对于预防传染病至关重要。预防性疫苗和治疗性疫苗的接种对于控制疾病爆发和降低盛行率的公共卫生措施至关重要。针对糖尿病、高血压和心臟病等慢性病的有效管理策略至关重要。这包括透过远距医疗服务、远端监控工具和行动医疗应用程式进行的定期监测，以支援患者遵守治疗计划并保持整体健康。

人工智慧（AI）和穿戴式装置等创新技术的结合，实现了即时健康监测，增强了预防保健。这些工具可以追踪生命体征、体力活动和其他健康指标，为医疗保健提供者提供潜在风险在升级为严重问题之前的宝贵见解。这些因素推动了全球预防医疗技术和服务市场的扩张。

市场动态：

驱动因素与约束因素

医疗科技创新

医疗技术的创新是全球预防医疗技术和服务市场成长的关键驱动力。这些进步从根本上改变了医疗保健服务，将重点从被动治疗转向主动预防。

人工智慧技术正在透过分析大量资料集来识别模式和预测健康风险，从而彻底改变诊断和治疗计划。例如，人工智慧演算法可以非常精确地检测出癌症等疾病的早期迹象，使医疗保健提供者能够在病情恶化之前采取预防措施。此外，人工智慧简化了管理任务，使医疗专业人员能够更加专注于患者护理。远距医疗平台中人工智慧诊断工具的整合提高了准确性和效率，促进了更具预防性的护理方法。

穿戴式装置已经取得了显着的进步，可以持续监测心率和血糖水平等各种健康指标。这些设备有助于及早发现潜在问题，使个人能够掌控自己的健康，这对于及时介入至关重要。穿戴式装置与医疗保健系统的结合可以实现即时资料共享，增强个人化护理。

医疗技术的创新对于推动全球预防性医疗技术和服务市场的发展至关重要，它可以增强医疗服务的机会、提高诊断准确性、透过穿戴式装置增强患者能力、并透过人工智慧和预测分析促进个人化介入。这些发展代表了一种变革性的健康管理方法，该方法优先考虑预防和主动护理策略。

此外，行业主要参与者的创新发布和政府倡议将推动全球预防医疗技术和服务市场的成长。例如，2024 年 12 月，富士医疗与 Dr. Kutty's Healthcare 的合资企业 NURA 在喀拉拉邦卡利卡特推出了首家由人工智慧驱动的健康筛检中心。该设施标誌着 NURA 向印度医疗保健市场战略扩张迈出的重要一步，旨在提高早期疾病检测能力。该中心每天最多可筛检 50 人，专注于检测癌症和代谢综合征，并计划在未来筛检运动综合征。

此外，2024年11月，富士通宣布开发Policy Twin，这是一项创新的数位孪生技术，旨在模拟地方政府政策的社会影响。这项创新工具旨在透过提供数据驱动的见解，使政策制定者能够优化决策，从而提高市政预防性医疗服务的有效性。所有这些因素都要求全球预防医疗技术和服务市场。此外，对数位健康解决方案扩展的需求不断增长，促进了全球预防医疗技术和服务市场的扩张。

资料安全和隐私问题

资料安全和隐私问题将阻碍全球预防医疗技术和服务市场的成长。随着预防性医疗保健越来越依赖数位平台进行个人化护理，对资料安全和病患隐私的担忧显着加剧。依赖科技收集和分享敏感病患资讯引发了对未经授权的存取、资料外洩和侵犯隐私的担忧。这种日益增长的担忧导致消费者对医疗保健组织保护其资料的能力产生明显的不信任，这可能会阻止个人使用预防性医疗保健服务。

例如，根据 HIPAA Journal 的资料，2024 年医疗保健产业的资料外洩事件大幅增加，共发生 13 起事件，每起事件涉及超过 100 万笔医疗记录。在这些事件中，Change Healthcare 资料外洩事件成为史上最大的医疗保健资料外洩事件，影响了近 1.9 亿人。这起事件凸显了医疗保健资料安全的严重漏洞，并强调了该领域网路攻击的威胁日益升级。因此，上述因素可能会限制全球预防医疗技术和服务市场的潜在成长。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动态

  • 影响因素
    • 驱动程式
      • 医疗科技创新
    • 限制
      • 资料安全和隐私问题
    • 机会
    • 影响分析

第五章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 专利分析
  • 监管分析
  • SWOT 分析
  • 未满足的需求

第 6 章：按技术类型

  • 早期检测与筛检技术
    • 诊断影像
    • 基因检测
    • 生物标记检测
    • 其他的
  • 慢性病管理技术
    • 远距医疗服务
    • 远端监控工具
    • 行动健康应用程式
    • 其他的
  • 疫苗
    • 预防疫苗
    • 治疗性疫苗
  • 先进技术
    • 临床决策支援系统 (CDSS)
    • 药物管理系统
    • 电子健康纪录 (EHR) 系统
    • 其他的

第 7 章：按服务类型

  • 健康计划
  • 诊断服务
  • 病人教育服务
  • 其他的

第 8 章：按应用

  • 癌症预防与筛检
  • 传染病预防
  • 心血管疾病管理
  • 糖尿病管理
  • 其他的

第 9 章：按最终用户

  • 医疗保健提供者
  • 医疗保健付款人
  • 其他的

第 10 章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 11 章：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 併购分析

第 12 章：公司简介

  • Medtronic
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 关键进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • Myriad Genetics, Inc.
  • Abbott.
  • Quest Diagnostics.
  • Merck & Co., Inc.,
  • GSK plc.
  • Omnicell
  • McKesson Corporation
  • OMRON Healthcare
  • Pfizer Inc.
  • Sanofi

第 13 章：附录

简介目录
Product Code: PH9109

The global preventive healthcare technologies and services market reached US$ 265.29 billion in 2024 and is expected to reach US$ 781.51 billion by 2033, growing at a CAGR of 12.2% during the forecast period 2025-2033.

Preventive healthcare technologies and services are crucial elements of contemporary healthcare systems, emphasizing proactive strategies to prevent diseases and effectively manage health conditions. This process involves utilizing diagnostic tools to identify diseases before they manifest symptoms. Techniques such as diagnostic imaging, genetic testing, and biomarker testing are vital for early detection of conditions like cancer and cardiovascular diseases, significantly enhancing treatment success rates and survival outcomes.

Vaccines are essential for preventing infectious diseases by training the immune system to recognize and combat pathogens. The administration of both preventive vaccines and therapeutic vaccines is fundamental to public health initiatives focused on controlling disease outbreaks and reducing prevalence. Effective management strategies for chronic conditions such as diabetes, hypertension, and heart disease are critical. This includes regular monitoring facilitated by telehealth services, remote monitoring tools, and mobile health applications, which support patients in adhering to treatment plans and maintaining their overall health.

The incorporation of innovative technologies, including artificial intelligence (AI) and wearable devices, enhances preventive care by enabling real-time health monitoring. These tools track vital signs, physical activity, and other health metrics, providing healthcare providers with valuable insights into potential risks before they escalate into serious issues. These factors have driven the global preventive healthcare technologies and services market expansion.

Market Dynamics: Drivers & Restraints

Innovations in Healthcare Technology

Innovations in healthcare technology are a critical driver of growth in the global preventive healthcare technologies and services market. These advancements are fundamentally transforming healthcare delivery, shifting the focus from reactive treatment to proactive prevention.

AI technologies are revolutionizing diagnostics and treatment planning by analyzing vast datasets to identify patterns and predict health risks. For instance, AI algorithms can detect early signs of diseases such as cancer with remarkable precision, enabling healthcare providers to implement preventive measures before conditions worsen. Additionally, AI streamlines administrative tasks, allowing healthcare professionals to focus more on patient care. The integration of AI-driven diagnostic tools within telehealth platforms enhances both accuracy and efficiency, promoting a more preventive approach to care.

Wearable devices have significantly advanced, offering continuous monitoring of various health metrics like heart rate and glucose levels. These devices empower individuals to take control of their health by facilitating early detection of potential issues, which is critical for timely intervention. The integration of wearables with healthcare systems enables real-time data sharing, enhancing personalized care.

Innovations in healthcare technology are essential for advancing the global preventive healthcare technologies and services market by enhancing access to care, improving diagnostic accuracy, empowering patients through wearable devices, and facilitating personalized interventions via AI and predictive analytics. These developments represent a transformative approach to health management that prioritizes prevention and proactive care strategies.

Furthermore, key players in the industry have innovative launches and government initiatives that would drive this global preventive healthcare technologies and services market growth. For instance, in December 2024, NURA, a joint venture between Fujifilm Healthcare and Dr. Kutty's Healthcare, launched its first AI-driven health screening center in Calicut, Kerala. This facility marks a significant step in NURA's strategic expansion into the Indian healthcare market, aiming to improve early disease detection capabilities. The center is designed to screen up to 50 individuals daily, focusing on the detection of cancer and metabolic syndromes, with plans to include screenings for locomotive syndrome in the future.

Also, in November 2024, Fujitsu announced the development of Policy Twin, an innovative digital twin technology designed to simulate the social impact of local government policies. This innovative tool aims to enhance the effectiveness of municipal preventive healthcare services by providing data-driven insights that enable policymakers to optimize their decisions. All these factors demand the global preventive healthcare technologies and services market. Moreover, the rising demand for the expansion of digital health solutions contributes to the global preventive healthcare technologies and services market expansion.

Data Security and Privacy Concerns

The data security and privacy concerns will hinder the growth of the global preventive healthcare technologies and services market. As preventive healthcare increasingly relies on digital platforms for personalized care, concerns about data security and patient privacy have escalated significantly. The reliance on technology for collecting and sharing sensitive patient information raises fears regarding unauthorized access, data breaches, and privacy violations. This growing apprehension has led to a notable distrust among consumers regarding healthcare organizations' ability to protect their data, potentially deterring individuals from utilizing preventive healthcare services.

For instance, according to the HIPAA Journal data stated that in 2024, the healthcare sector experienced a significant surge in data breaches, with 13 incidents involving more than 1 million healthcare records each. Among these incidents, the Change Healthcare breach emerged as the largest healthcare data breach in history, impacting nearly 190 million individuals. This incident highlights the critical vulnerabilities in healthcare data security and underscores the escalating threat of cyberattacks within the sector. Thus, the above factors could be limiting the global preventive healthcare technologies and services market's potential growth.

Segment Analysis

The global preventive healthcare technologies and services market is segmented based on technology type, service type, application, end-user, and region.

Technology Type:

The early detection and screening technologies segment is expected to dominate the global preventive healthcare technologies and services market share

The early detection and screening technologies segment holds a major portion of the global preventive healthcare technologies and services market share and is expected to continue to hold a significant portion of the global preventive healthcare technologies and services market share during the forecast period.

Early detection and screening technologies are critical for proactive healthcare management, enabling timely interventions that can significantly improve patient outcomes. These technologies assist in identifying diseases at an early stage when they are often more treatable, thereby reducing morbidity and mortality rates associated with conditions like cancer. This segment includes a range of advanced technologies and methodologies aimed at facilitating early diagnosis, particularly for chronic diseases and cancers.

Key Technologies in Early Detection and Screening include X-ray, CT, MRI, and Ultrasound. These imaging modalities are fundamental in detecting abnormalities within the body. X-rays are widely used to identify bone fractures and certain lung conditions. CT (Computed Tomography) scans provide detailed cross-sectional images of organs, aiding in the early detection of tumors.MRI (Magnetic Resonance Imaging) is particularly effective for soft tissue evaluation, making it invaluable in diagnosing conditions like brain tumors or joint disorders.

Ultrasound is often utilized for prenatal screenings and examining soft tissues. Genetic testing allows for the identification of inherited conditions that may predispose individuals to certain diseases, such as breast or colon cancer. Biomarkers serve as measurable indicators of biological processes or conditions. Tests that analyze blood or other bodily fluids to detect biomarkers can indicate the presence of diseases like cancer or diabetes before symptoms manifest.

Furthermore, key players in the industry initiatives and introducing awareness programs would propel this segment's growth in the global preventive healthcare technologies and services market. For instance, in February 2024, the National Institutes of Health (NIH) established the Cancer Screening Research Network (CSRN), a clinical trials network dedicated to evaluating new technologies for cancer screening. This initiative is part of the Biden-Harris administration's Cancer Moonshot, which aims to improve early cancer detection when treatment is often more effective. The CSRN will investigate methods to identify cancers at earlier stages, enhancing the potential for successful treatment outcomes.

Also, in December 2024, Apollo Cancer Centre introduced the LungLife Screening Program, a pioneering initiative aimed at the early detection of lung cancer through advanced low-dose computed tomography (LDCT) technology. This program is designed to identify high-risk individuals at an early stage, significantly improving the chances of successful treatment. These factors have solidified the segment's position in the global preventive healthcare technologies and services market.

Geographical Analysis

North America is expected to hold a significant position in the global preventive healthcare technologies and services market share

North America holds a substantial position in the global preventive healthcare technologies and services market and is expected to hold most of the market share.

The increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and obesity is a significant driver of market growth. According to the Centers for Disease Control and Prevention (CDC), approximately 60% of adults in the U.S. have a chronic illness, with 40% having two or more conditions. This escalating burden necessitates effective preventive healthcare measures to manage these diseases proactively.

The aging population in North America significantly contributes to the demand for preventive healthcare services. By 2030, all baby boomers will be over the age of 65, which leads to an increased focus on preventive measures aimed at enhancing quality of life and managing age-related health issues.

Continuous innovations in healthcare technologies-including telehealth, mobile health applications, and advanced diagnostic tools (such as AI-driven imaging and genomic testing)-enhance the effectiveness and accessibility of preventive healthcare services. These advancements facilitate earlier disease detection and better management of chronic conditions.

Furthermore, in this region a major of kay players' presence, well-advanced healthcare infrastructure, investments, and awareness campaigns would drive this global preventive healthcare technologies and services market. For instance, in May 2024, Superpower, a healthcare platform dedicated to personalized and preventative medicine, successfully secured $4 million in pre-seed funding to launch its innovative platform focused on enhancing longevity-oriented healthcare in India. This virtual platform aims to simplify access for individuals seeking tailored health solutions that emphasize prevention and overall well-being.

Also, in February 2024, Henry Schein, Inc. launched the Prevention is Power campaign, a multi-year public health awareness initiative led by the Henry Schein Cares Foundation (HSCF). This campaign aims to enhance health literacy and encourage patients to engage with integrated preventive care, ultimately targeting a reduction in chronic disease prevalence and overall healthcare costs. Thus, the above factors are consolidating the region's position as a dominant force in the global preventive healthcare technologies and services market.

Asia Pacific is growing at the fastest pace in the global preventive healthcare technologies and services market share

Asia Pacific holds the fastest pace in the global preventive healthcare technologies and services market and is expected to hold most of the market share.

The rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, and respiratory conditions significantly drives market growth in the APAC region. As lifestyles become more sedentary and dietary habits shift, the incidence of these diseases is increasing, necessitating effective preventive healthcare measures to manage these conditions proactively.

There is a notable increase in health awareness among consumers across APAC countries. Public health campaigns, educational initiatives, and improved access to information motivate individuals to engage in preventive healthcare practices, including regular screenings and vaccinations. This heightened awareness is crucial for fostering a culture of health and wellness.

Many governments in the APAC region are implementing policies aimed at promoting preventive healthcare. Initiatives targeting non-communicable diseases (NCDs) and funding for public health programs encourage the adoption of preventive services across various demographics, including remote areas.

Continuous advancements in healthcare technologies-including telehealth solutions, mobile health applications, and advanced diagnostic tools-enhance the accessibility and effectiveness of preventive healthcare services. These innovations enable earlier detection of diseases and better management of chronic conditions, making preventive care more efficient and user-friendly.

Furthermore, key player's strategies such as partnerships & collaborations, and innovative launches would drive this global preventive healthcare technologies and services market growth. For instance, in July 2024, Nervfit and MyCLNQ announced a strategic partnership aimed at enhancing technology-driven preventive healthcare in India. This collaboration will introduce an innovative system known as 'Technology-Enabled Care' (TEC), which merges Nervfit's expertise in wearable fitness technology with MyCLNQ's advanced health monitoring capabilities.

Also, in November 2024, Star Health Insurance, a leading health insurance provider in India, launched an innovative Corporate Social Responsibility (CSR) initiative called 'Star Arogya Digi Seva' in partnership with the Center for Chronic Disease and Control (CCDC). This innovative program aims to transform healthcare delivery in underserved communities by integrating telemedicine technology with Mobile Health Units (MHUs). Thus, the above factors are consolidating the region's position as the fastest-growing force in the global preventive healthcare technologies and services market.

Competitive Landscape

The major global players in the preventive healthcare technologies and services market include Medtronic, Myriad Genetics, Inc., Abbott., Quest Diagnostics., Merck & Co., Inc., GSK plc., Omnicell, McKesson Corporation, OMRON Healthcare, Pfizer Inc., and Sanofi among others.

Key Developments

  • In January 2025, Apollo ProHealth partnered with The Hindu to launch a new initiative aimed at providing the public with actionable health insights. This program is designed to enhance early awareness of health issues and empower individuals to make informed decisions regarding their health. By focusing on preventive measures, the initiative seeks to encourage proactive health management, enabling people to recognize potential health risks and take appropriate actions to mitigate them.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global preventive healthcare technologies and services market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Technology Type
  • 3.2. Snippet by Service Type
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Innovations in Healthcare Technology
    • 4.1.2. Restraints
      • 4.1.2.1. Data Security and Privacy Concerns
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Patent Analysis
  • 5.5. Regulatory Analysis
  • 5.6. SWOT Analysis
  • 5.7. Unmet Needs

6. By Technology Type

  • 6.1. Introduction
    • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Technology Type
    • 6.1.2. Market Attractiveness Index, By Technology Type
  • 6.2. Early Detection and Screening Technologies*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Diagnostic Imaging
    • 6.2.4. Genetic Testing
    • 6.2.5. Biomarker Testing
    • 6.2.6. Others
  • 6.3. Chronic Disease Management Technologies
    • 6.3.1. Telehealth Services
    • 6.3.2. Remote Monitoring Tools
    • 6.3.3. Mobile Health Applications
    • 6.3.4. Others
  • 6.4. Vaccines
    • 6.4.1. Preventive Vaccines
    • 6.4.2. Therapeutic Vaccines
  • 6.5. Advanced Technologies
    • 6.5.1. Clinical Decision Support Systems (CDSS)
    • 6.5.2. Medication Management Systems
    • 6.5.3. Electronic Health Records (EHR) Systems
    • 6.5.4. Others

7. By Service Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 7.1.2. Market Attractiveness Index, By Service Type
  • 7.2. Wellness Programs*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Diagnostic Services
  • 7.4. Patient Education Services
  • 7.5. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Cancer Prevention and Screening*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Infectious Disease Prevention
  • 8.4. Cardiovascular Disease Management
  • 8.5. Diabetes Management
  • 8.6. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Healthcare Providers*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Healthcare Payers
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Medtronic*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio
      • 12.1.2.1. Product Description
      • 12.1.2.2. Product Key Performance Indicators (KPIs)
      • 12.1.2.3. Historic and Forecasted Product Sales
      • 12.1.2.4. Product Sales Volume
    • 12.1.3. Financial Overview
      • 12.1.3.1. Company Revenue's
      • 12.1.3.2. Geographical Revenue Shares
      • 12.1.3.3. Revenue Forecasts
    • 12.1.4. Key Developments
      • 12.1.4.1. Mergers & Acquisitions
      • 12.1.4.2. Key Product Development Activities
      • 12.1.4.3. Regulatory Approvals etc.
    • 12.1.5. SWOT Analysis
  • 12.2. Myriad Genetics, Inc.
  • 12.3. Abbott.
  • 12.4. Quest Diagnostics.
  • 12.5. Merck & Co., Inc.,
  • 12.6. GSK plc.
  • 12.7. Omnicell
  • 12.8. McKesson Corporation
  • 12.9. OMRON Healthcare
  • 12.10. Pfizer Inc.
  • 12.11. Sanofi

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us